[Immuneprophylaxis of purulent and septic complications with Derinat at surgical treatment of calculous cholecystitis].
Zubeev
P S
PS
Strakhov
A V
AV
Maksimychev
V N
VN
Motylev
I M
IM
D002764:Cholecystitis / Q000601:surgery*; D005500:Follow-Up Studies; D042882:Gallstones / Q000601:surgery*; D006684:HLA-DR Antigens / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects / Q000276:immunology; D007155:Immunologic Factors / Q000008:administration & dosage / Q000627:therapeutic use*; D007273:Injections, Intramuscular; D018805:Sepsis / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D013492:Suppuration / Q000276:immunology / Q000517:prevention & control; D013530:Surgical Wound Infection / Q000150:complications / Q000276:immunology / Q000517:prevention & control*; D013601:T-Lymphocytes / Q000276:immunology; D016896:Treatment Outcome
D006684:HLA-DR Antigens; D007155:Immunologic Factors